Q4 2024 Earnings Call Transcript March 5, 2025 Kamada Ltd. beats earnings expectations. Reported EPS is $0.07, expectations ...

Q4 2024 Earnings Call Transcript March 5, 2025 EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.54. Tessa Romero – JPMorgan: Yigal ...

Kamada Ltd (KMDA) reports a 13% revenue increase and unveils plans for biosimilar launches and plasma center expansions.

U.S. Food and Drug Administration (FDA) granted accelerated approval of Ziihera® (zanidatamab-hrii) for the treatment of adults with previously-treated, unresectable or metastatic HER2-positive (HER2+ ...

Record Year with Total 2024 Revenuesof $161.0Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up ...

Wall Street is generally afraid of uncertainty, but with adversity also comes opportunity. Find out my 2 picks that have well ...

Pason Systems Inc. ( OTCQX:PSYTF) Q4 2024 Earnings Conference Call February 28, 2025 11:00 AM ET Celine Boston - Chief Financial Officer Jon Faber - President and Chief Executive Officer Keith Mackey ...

Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

Q4 2024 Earnings Call Transcript February 27, 2025Ironwood Pharmaceuticals, Inc. misses on earnings expectations.

Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call ...